VYNE Therapeutics Inc.
Pharmaceutical Preparations · NEW HAVEN · CT
Moderate confidence (50%)
Updated Oct 11, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: VYNE Therapeutics Inc. received a delisting notice from its exchange (Mar 11, 2026)
Timeline
Every material event, newest first. History is never overwritten.
VYNE Therapeutics Inc. received a delisting notice from its exchange
Mar 11, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed in a Current Report on Form 8-K filed by VYNE Therapeutics Inc. (the Company ) on September 12, 2025, the Company received a notification from The Nasdaq Stock Market, LLC ( Nasdaq ) that the Company is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company s common stock (the Common Stock ) was below $1.00 per share for 30 co…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker YARW on Nasdaq.
- SEC CIK
- 0001566044
- Website
- —
- —
- Headquarters
- NEW HAVEN, CT
- Also known as
- Menlo Therapeutics Inc., Tigercat Pharma, Inc., VYNE Therapeutics Inc.
- Legal entities
- VYNE Therapeutics Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Yarrow Bioscience, Inc. — Pharmaceutical Preparations (SIC 2834) — NEW HAVEN, CT
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed in a Current Report on Form 8-K filed by VYNE Therapeutics Inc. (the Company ) on September 12, 2025, the Company received a notification from The Nasdaq Stock Market, LLC ( Nasdaq ) that the Company is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company s common stock (the Common Stock ) was below $1.00 per share for 30 co…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:32 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:47 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.